On May 25, 2023, Cyclerion Therapeutics, Inc. closed the transaction. The transaction included participation from a single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 USD | +3.75% | +0.73% | -17.31% |
1st Jan change | Capi. | |
---|---|---|
-17.31% | 7.03M | |
+52.63% | 55.7B | |
+40.74% | 39.91B | |
-5.89% | 39.57B | |
-5.56% | 28.16B | |
+15.80% | 26.3B | |
-20.20% | 18.94B | |
+31.48% | 12.17B | |
+26.33% | 12.12B | |
+1.26% | 12.12B |
- Stock Market
- Equities
- CYCN Stock
- News Cyclerion Therapeutics, Inc.
- Cyclerion Therapeutics, Inc. announced that it has received $5.000001 million in funding